[Trials in head and neck cancer - Highlights of the ASCO Annual Meeting 2021]. / Therapiestudien zu Kopf-Hals-Karzinomen ­ Highlights der ASCO-Jahrestagung 2021.

The therapeutic options in head and neck oncology are rapidly developing, especially through the use of checkpoint inhibitors. Currently, numerous therapeutic studies with new molecular targets or new drug combinations are underway in patients with head and neck cancer. The most important results of the studies presented at the ASCO Annual Meeting 2021 on head and neck cancer will be presented in this paper.